MedTrace Logo

Effect and Feasibility of Non-linear Periodized Resistance Training in People With COPD

NCT03518723 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2024-05-14

No results posted yet for this study

Summary

This study aims at improving the knowledge about resistance training for people with COPD. Resistance training is an important part of pulmonary rehabilitation when the goal is to improve muscular endurance and strength. The study will evaluate the effects and the feasibility of two resistance training programs for people with COPD using a parallel group design. One program will include a larger day-to-day variation (i.e. non-linear periodization) and the progression will be guided by ratings of dyspnea, muscle fatigue, and exertion. The other program will follow the established guidelines for resistance training for people with COPD. The programs will be evaluated for effects regarding muscular endurance, strength, intramuscular adaptions, functional preformance, dyspnea, and health related quality of life. The programs will also be evaluated for feasibility regarding the duration of training sessions, attendance rates, adverse events, and participant satisfaction. The hypothesis is that the non-linear periodization group will have superior effects and that feasibility aspects will be similar between groups.

Conditions

  • Pulmonary Disease
  • Chronic Obstructive

Interventions

OTHER

Non-linear Periodized Resistance Training

8 week non-linear periodized resistance training intervention, 3 sessions per week, 60 minutes per session

OTHER

Resistance training

8 week resistance training intervention, 3 sessions per week, 60 minutes per session

Sponsors & Collaborators

  • Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec

    collaborator OTHER

  • Radboud University Medical Center

    collaborator OTHER

  • Merem Pulmonary Rehabilitation Centre

    collaborator UNKNOWN

  • Umeå University

    lead OTHER

Principal Investigators

  • Andre Nyberg, PhD · Umeå University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-16
Primary Completion
2023-03-01
Completion
2023-03-01

Countries

  • Canada
  • Netherlands
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03518723 on ClinicalTrials.gov